--- title: "BCU-CP-59436 - Detoxification Services" ocid: "ocds-kuma6s-155749" canonical_url: "https://d3tenders.com/contract/?ocid=ocds-kuma6s-155749" markdown_url: "https://d3tenders.com/contract/ocds-kuma6s-155749.md" json_url: "https://d3tenders.com/contract/ocds-kuma6s-155749.json" source: "Sell2Wales" current_stage: "Tender" buyer: "NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES (HOSTED BY VELINDRE UNIVERSITY NHS TRUST)" published: "2025-09-16" --- # BCU-CP-59436 - Detoxification Services Buyer: NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES (HOSTED BY VELINDRE UNIVERSITY NHS TRUST) Current stage: Tender OCID: ocds-kuma6s-155749 [View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-kuma6s-155749) [Download OCDS JSON](https://d3tenders.com/contract/ocds-kuma6s-155749.json) ## Summary The NHS Wales Shared Services Partnership, hosted by Velindre University NHS Trust, has initiated an open procurement process to recommission inpatient substance misuse detoxification services in North Wales, under the title "BCU-CP-59436 - Detoxification Services". This tender falls within the health industry category and addresses a critical need for specialised care for individuals with substance dependencies. The procurement stage is currently at the tender phase, with a tender submission deadline set for midday on 7th October 2025. The service provision focuses on regions UKL11, UKL12, UKL13, and UKL23, highlighting areas with notable rates of substance misuse. The tender is valued at £5,100,000 and will utilise an electronic submission method through the eTender Wales portal. This tender presents significant business growth opportunities, particularly for healthcare providers specialising in addiction services and inpatient care. Businesses with experience in delivering high-quality healthcare services and a strong understanding of managing co-morbid physical and psychiatric complications could find this tender well-suited to their capabilities. The procurement process will consider a balance of 30% cost and 70% quality, offering an incentive for businesses that prioritise service excellence. Furthermore, the procurement offers a potential contractual duration of three years, with the possibility of extending for two additional one-year periods, subject to supplier performance. Participation in this tender could enhance business credibility and expand service reach within the critical healthcare sector in Wales. ## Notice The MHLD Directorate are seeking approval to recommission the inpatient substance misuse detoxification service for North Wales. The inpatient substance misuse detoxification service is for patients who have physical and/or psychological dependency to one or more substances with physical or psychiatric complications (co-morbidity) if they require a higher level of care than can be provided safely in the community. North Wales is an outlier in several areas for substance misuse as outlined. In 2022/2023, 19 of the 22 Local Authority areas in Wales saw a decrease in rates of individuals admitted to hospital with an alcohol-specific condition. The only 3 Local Authority areas that saw an increase were Gwynedd (4 per cent) Anglesey (7 per cent) and Wrexham (10 per cent). Betsi Cadwaladr University Health Board (BCUHB) area has the highest rate of admissions related to illicit drugs (152.1 per 100,000 population) across Wales. When looking at deaths from drug misuse for 2020-22 by local authority, Wrexham is in the top 5 local authorities with a population prevalence of 8.6 per 100,000 population compared with the Welsh average being 6.6 per 100,000 of the population. The number of patients referred for inpatient substance misuse detoxification service has steadily increased over the last three years. This is from 194 admissions in 2022, 227 admissions in 2023 and 183 in 2024 To ensure that the existing service delivery model is still fit for purpose a full options appraisal process has been undertaken following the Better Business case methodology and explored a range of potential options including BCUHB delivery and external procurement. ### Lot Information Lot 1 The MHLD Directorate are seeking approval to recommission the inpatient substance misuse detoxification service for North Wales. The inpatient substance misuse detoxification service is for patients who have physical and/or psychological dependency to one or more substances with physical or psychiatric complications (co-morbidity) if they require a higher level of care than can be provided safely in the community. North Wales is an outlier in several areas for substance misuse as outlined. In 2022/2023, 19 of the 22 Local Authority areas in Wales saw a decrease in rates of individuals admitted to hospital with an alcohol-specific condition. The only 3 Local Authority areas that saw an increase were Gwynedd (4 per cent) Anglesey (7 per cent) and Wrexham (10 per cent). Betsi Cadwaladr University Health Board (BCUHB) area has the highest rate of admissions related to illicit drugs (152.1 per 100,000 population) across Wales. When looking at deaths from drug misuse for 2020-22 by local authority, Wrexham is in the top 5 local authorities with a population prevalence of 8.6 per 100,000 population compared with the Welsh average being 6.6 per 100,000 of the population. The number of patients referred for inpatient substance misuse detoxification service has steadily increased over the last three years. This is from 194 admissions in 2022, 227 admissions in 2023 and 183 in 2024 To ensure that the existing service delivery model is still fit for purpose a full options appraisal process has been undertaken following the Better Business case methodology and explored a range of potential options including BCUHB delivery and external procurement. Please see Information for Bidders document on the Bravo Solutions portal for further details. Betsi Cadwaladr University Health Board recognises the importance of the Welsh language to the communities it serves. Consequently, responses to an invitation to quote or tender will be accepted in Welsh as well as English. However, please note that tender responses submitted only in Welsh will be translated by the Trust into English before consideration. Those involved in translating the document will be barred from taking decisions on awarding tenders. The tender will be awarded based on 30% cost & 70% quality as detailed in the ITT document. Please note that the tender closing date is 07/10/2025 at midday and any late submissions will not be considered. The etenderwales bravosolution ref:Project: project_59436 and itt_120050 Please direct all queries relating to this tender via the messaging function of the Bravo portal. More details can be found at https://etenderwales.bravosolution.co.uk. Renewal: an option to extend for two (2) further one (1) year periods, at the discretion of the Health Board and subject to supplier performance. ## Key Details | Field | Value | | --- | --- | | Publication source | Sell2Wales | | Latest notice | https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=155749 | | Notice type | OJEU - F2 - Contract Notice | | Procurement type | Standard | | Procurement category | Services | | Procurement method | Open | | Procurement method details | Open procedure | | Tender suitability | Not specified | | Awardee scale | Not specified | | All stages | Tender | ## Dates | Field | Value | | --- | --- | | Publication date | 16 Sep 2025 | | Submission deadline | 7 Oct 2025 | | Future notice date | Not specified | | Award date | Not specified | | Contract period | Not specified | | Recurrence | 2028 | ## Values | Field | Value | | --- | --- | | Tender value | £5,100,000 | | Lots value | Not specified | | Awards value | Not specified | | Contracts value | Not specified | ## Status | Field | Value | | --- | --- | | Tender status | Active | | Lots status | Active | | Awards status | Not specified | | Contracts status | Not specified | ## Buyer | Field | Value | | --- | --- | | Main buyer | NHS WALES SHARED SERVICES PARTNERSHIP-PROCUREMENT SERVICES (HOSTED BY VELINDRE UNIVERSITY NHS TRUST) | | Locality | CARDIFF | | Post town | Cardiff | | Postcode | CF15 7QZ | | Country | Wales | | ITL 1 | TLL Wales | | ITL 2 | TLL5 South East Wales | | ITL 3 | TLL51 Central Valleys and Bridgend | | Local authority | Rhondda Cynon Taf | | Electoral ward | Taff's Well | | Westminster constituency | Cardiff North | | Delivery location | TLL11 Isle of Anglesey, TLL12 Gwynedd, TLL13 Conwy and Denbighshire, TLL23 Flintshire and Wrexham | ## CPV Codes ### Divisions - 85 - Health and social work services ### Codes - 85312500 - Rehabilitation services ## Release History - 16 Sep 2025 at 00:00 - Tender - OJEU - F2 - Contract Notice - https://www.sell2wales.gov.wales/search/search_switch.aspx?ID=155749 ## Documents - https://www.sell2wales.gov.wales/search/show/search_view.aspx?ID=SEP544738 BCU-CP-59436 - Detoxification Services - The MHLD Directorate are seeking approval to recommission the inpatient substance misuse detoxification service for North Wales. The inpatient substance misuse detoxification service is for patients who have physical and/or psychological dependency to one or more substances with physical or psychiatric complications (co-morbidity) if they require a higher level of care than can be provided safely in the community. North Wales is an outlier in several areas for substance misuse as outlined. In 2022/2023, 19 of the 22 Local Authority areas in Wales saw a decrease in rates of individuals admitted to hospital with an alcohol-specific condition. The only 3 Local Authority areas that saw an increase were Gwynedd (4 per cent) Anglesey (7 per cent) and Wrexham (10 per cent). Betsi Cadwaladr University Health Board (BCUHB) area has the highest rate of admissions related to illicit drugs (152.1 per 100,000 population) across Wales. When looking at deaths from drug misuse for 2020-22 by local authority, Wrexham is in the top 5 local authorities with a population prevalence of 8.6 per 100,000 population compared with the Welsh average being 6.6 per 100,000 of the population. The number of patients referred for inpatient substance misuse detoxification service has steadily increased over the last three years. This is from 194 admissions in 2022, 227 admissions in 2023 and 183 in 2024 To ensure that the existing service delivery model is still fit for purpose a full options appraisal process has been undertaken following the Better Business case methodology and explored a range of potential options including BCUHB delivery and external procurement. ## Notice URLs - http://nwssp.nhs.wales/ourservices/procurement-services/ - http://www.sell2wales.gov.wales/search/search_switch.aspx?ID=155749 - https://api.sell2wales.gov.wales/v1?lang=cy/Notice?id=ocds-kuma6s-155749 - https://etenderwales.bravosolution.co.uk - https://etenderwales.bravosolution.co.uk/web/login.shtml ## Provenance This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-kuma6s-155749. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-kuma6s-155749.json.